The role of MK-801 in sensitization to stimulants

Brain Research Reviews

Volumn 35, Issue 2, 2001, Pages 97-114

  Sripada, S ^a   Gaytan, O ^a   Swann, A ^a   Dafny, N ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Amphetamine; Behavioral sensitization; Cocaine; Conditioning; Methylphenidate; MK 801; Motor effect; Psychomotor stimulant; State dependent learning

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; AMPHETAMINE; APOMORPHINE; BROMOCRIPTINE; CENTRAL STIMULANT AGENT; COCAINE; DIZOCILPINE; EXCITATORY AMINO ACID; METHAMPHETAMINE; METHYLPHENIDATE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

AMINO ACID TRANSPORT; BEHAVIOR; CONDITIONING; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; HUMAN; LOCOMOTION; MANIC DEPRESSIVE PSYCHOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSITIZATION; STATE DEPENDENT LEARNING; SUBSTANCE ABUSE; TREATMENT OUTCOME;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DIZOCILPINE MALEATE; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY AMINO ACIDS; HUMANS;

EID: 0035013063     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(00)00046-1     Document Type: Review

References (93)

1. Effects of NMDA receptor antagonists on cocaine-induced motor activity in rats
2. Conditioned increase in place preference by access to noves objects: Antagonism by MK-801
3. Theoretical explanation of drug-dissociated behaviors
4. Long-lasting potentiation of synaptic transmission in the dentate area of the anesthetized rabbit following stimulation of the perforant path
5. Acute behavioral effects of MK-801 in the mouse
6. Metabolic and experiential factors in the behavioral response to repeated amphetamine
7. D-amphetamine-induced behavioral sensitization: Implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation
8. The NMDA receptor and cocaine: Evidence that MK-801 can induce behavioral sensitization effects
9. The NMDA antagonist MK-801 can impair attention to exteroceptive stimuli
10. MK-801 disrupts the expression but not the development of bromocriptine sensitization: A state-dependency interpretation
11. The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice
12. Effects of dopaminergic and glutamatergic receptor antagonists on the establishment and expression of conditioned locomotion to cocaine in rats
13. A study of the alcohol-tolerance effect and an introduction of a new behavioral technique
14. Multiple within-day conflict testing to define the time course of anxiolytic drug effects
15. The effects of alcohol on conflict behavior in the albino rat
16. Absence of environment-specificity in morphine tolerance acquired in nondistinctive environments: Habituation or stimulus overshadowing?
17. Time course effects of MK-801: The relationship between brain neurochemistry and behavior
18. The noncompetitive NMDA receptor blocker dizocilpine potentiates serotonergic function
19. Effect of the chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat
20. The development of behavioral sensitization to apomorphine is blocked by MK-801
21. MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens
22. Effects of the competitive N-methyl-D-aspartate receptor antagonist, CPP, on the development and expression of conditioned hyperactivity and sensitization induced by cocaine
23. Continuous amphetamine intoxication: An animal model of the acute psychotic episode
24. Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice
25. Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice
26. Sensitization to locomotor effects of methylphenidate in the rat
27. Blockade of sensitization to methylphenidate by MK-801: Partial dissociation from motor effects
28. Diurnal differences in sensitization to methylphenidate
29. MK-801 blocks the development of sensitization to the locomotor effects of methylphenidate
30. Conditioned responses in curarized striate muscle in dogs
31. Hyperactivity, hyper-reactivity, and sensorimotor deficits induced by low doses of the N-methyl-D-aspartate non-competitive channel blocker MK-801
32. Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems
33. Antagonists of N-methyl-D-aspartate receptors partially prevent the development of cocaine sensitization
34. Inhibition of cocaine sensitization by MK-801, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: Evaluation by ambulatory activity in mice
35. NMDA antagonists make learning and recall state-dependent
36. MK-801 prevents the development of behavioral sensitization during repeated morphine administration
37. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine
38. The pharmacology and neural circuitry of sensitization to psychostimulants
39. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
40. Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801
41. Amphetamine behavioral sensitization and the excitatory amino acids
42. Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopamine-receptor supersensitivity in mice
43. MK-801, a proposed non-competitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys
44. Characteristics of the ambulation-increasing effect of the noncompetitive NMDA antagonist MK-801 in mice: Assessment by the coadministration with central-acting drugs
45. Effects of repeated MK-801 on ambulation in mice and in sensitization following methamphetamine
46. Psychomotor stimulant-induced sensitization: Behavioral and neurochemical correlates
47. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations
48. Can the 'state-dependency' hypothesis explain prevention of amphetamine sensitization in rats by NMDA receptor antagonists?
49. Pavlovian conditioning of drug reactions: Some implications for problems of drug addiction
50. Long-term potentiation: Persisting problems and recent results
51. Subchronic administration of MK-801 in the rat decreases cortical binding of [3H]-APS, suggesting down-regulation of the cortical N-methyl-O-aspartate receptors
52. Delayed application of MK-801 attenuates development of morphine tolerance in rats
53. Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens
54. An alternative to the LTP orthodoxy: A plasticity-pathology continuum model
55. Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: Importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat
56. The role of NMDA receptors in learning and memory
57. Phencyclidine-like discriminative stimulus effects of polyamine modulators of N-methyl-D-aspartate receptor activity in rats
58. Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine
59. 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB
60. Experimental methods for the study of state-dependent learning
61. State dependent learning and drug discriminations
62. The effects of MK-801 on body temperature and behavior in the rat: Cross-sensitization and cross-tolerance with phencyclidine
63. L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine
64. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
65. Development and expression of sensitization to cocaine's reinforcing properties: Role of NMDA receptors
66. Determination of serum and brain concentrations of neuroprotective and non-neuroprotective doses of MK-801
67. Behavioral and neurochemical correlates of repeated D-amphetamine administration
68. Does dizocilpine (MK-801) selectively block the enhanced responsiveness to repeated amphetamine administration?
69. Animal models of stimulant-induced psychosis
70. The dose-related effects of MK-801 on acute and chronic methylphenidate administration
71. Pharmacological conditioning and drug effects
72. State-dependent learning and morphine tolerance
73. Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801
74. Conditioned drug effects
75. Extinction procedures abolish conditioned stimulus control but spare sensitized responding to amphetamine
76. MK-801 transiently mask the expression of sensitization to methylphenidate
77. MK-801-induced stereotypy and its antagonism by neuroleptic drugs
78. The behavioral effects of MK-801: A comparison with antagonists acting non-competitively and competitively at the NMDA receptor
79. Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioral sensitization
80. Competitive and non-competitive N-methyl-D-aspartate antagonists fail to prevent the induction of methamphetamine-induced sensitization
81. Overshadowing effects in the stimulus-control of morphine analgesic tolerance
82. Phencyclidine-like discriminative stimulus properties of MK-801 in rats
83. Plasma and CSF levels of dizocilpine (MK-801) required for neuroprotection in the quinolate-injected rat striatum
84. MK-801 (dizocilpine): Synergist and conditioned stimulus in bromocriptine-induced psychomotor sensitization
85. Immediate and long-lasting effects of MK-801 on motor activity, spatial navigation in a swimming pool, and EEG in the rat
86. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants
87. Coadministration of MK-801 with amphetamine, cocaine, or morphine prevents rather than transiently masks the development of behavioral sensitization
88. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine
89. MK-801 does not prevent the acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens
90. The role of instrumental learning in behavioral tolerance to drugs
91. Behavioral effects of MK-801 in the rat
92. Asymmetric cross-sensitization to the locomotor stimulant effects of phencyclidine and MK-801
93. Comparison of two forms of long-term potentiation in single hippocampal neurons